|
|
Article: Rodman & Renshaw, LLC Initiates Coverage of Provectus Pharmaceuticals, Inc. With A Market Perform Rating.
- Article from:
- Business Wire
- Article date:
- November 27, 2007
CopyrightCOPYRIGHT 2007 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
NEW YORK -- Rodman & Renshaw, LLC initiated research coverage of Provectus Pharmaceuticals, Inc. (NASDQ: PVCT - News) with a Market Perform Rating. Elemer Piros, PH.D, Senior Biotechnology Analyst, issued the report.
About Rodman & Renshaw, LLC
Rodman & Renshaw is a full service investment bank dedicated to providing investment banking services to companies that have significant recurring capital needs due to their growth and development strategies, along with research and sales and trading services to institutional investor clients that focus on such companies. Through its AcumenBioFin(TM) division, Rodman is a leading investment banking firm to the ...
Related newspaper, magazine, and journal articles:
|
|
Article: Provectus Pharmaceuticals' Craig Dees, Ph.D. to ...
PR Newswire;
October 15, 2004 ;
700+ words
... ... Craig Dees, Ph.D., CEO of Provectus Pharmaceuticals, Inc. (BULLETIN BOARD: PVCT ... focus on recent developments at Provectus Pharmaceuticals including the use of pharmacological ... and his fellow scientists at Provectus Pharmaceuticals Inc. have discovered a new method ...
|
|